Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Valent

Showing results (291-300 of 316) with videos related to

Pageof 32
Sort By:
Leukemia|September 10, 2015
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growthB Peter, G E Winter, K Blatt, et al.
Leukemia|June 10, 2015
Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemiaG Wedeh, S Cerny-Reiterer, G Eisenwort, et al.
Current Cancer Drug Targets|June 11, 2009
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapyK V Gleixner, M Mayerhofer, A Vales, et al.
The Journal of Biological Chemistry|March 21, 1997
Molecular and functional characterization of the urokinase receptor on human mast cellsC Sillaber, M Baghestanian, R Hofbauer, et al.
Leukemia|August 1, 2017
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target siteE Hadzijusufovic, K Albrecht-Schgoer, K Huber, et al.
Allergy|May 1, 2008
Characterization of Der p 21, a new important allergen derived from the gut of house dust mitesM Weghofer, Y Dall'Antonia, M Grote, et al.
Leukemia|December 19, 2017
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cellsB Peter, S Bibi, G Eisenwort, et al.
Leukemia Research|May 30, 2001
Diagnostic criteria and classification of mastocytosis: a consensus proposalP Valent, H P Horny, L Escribano, et al.
Leukemia|August 31, 2016
NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitorsK Byrgazov, R Kastner, M Gorna, et al.
Leukemia|August 27, 2015
NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cellsA K Jayavelu, J P Müller, R Bauer, et al.
Pageof 32

Showing results (291-300 of 316) with videos related to

Sort By:
Pageof 32
Leukemia|September 10, 2015
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growthB Peter, G E Winter, K Blatt, et al.
Leukemia|June 10, 2015
Identification of bromodomain-containing protein-4 as a novel marker and epigenetic target in mast cell leukemiaG Wedeh, S Cerny-Reiterer, G Eisenwort, et al.
Current Cancer Drug Targets|June 11, 2009
Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapyK V Gleixner, M Mayerhofer, A Vales, et al.
The Journal of Biological Chemistry|March 21, 1997
Molecular and functional characterization of the urokinase receptor on human mast cellsC Sillaber, M Baghestanian, R Hofbauer, et al.
Leukemia|August 1, 2017
Nilotinib-induced vasculopathy: identification of vascular endothelial cells as a primary target siteE Hadzijusufovic, K Albrecht-Schgoer, K Huber, et al.
Allergy|May 1, 2008
Characterization of Der p 21, a new important allergen derived from the gut of house dust mitesM Weghofer, Y Dall'Antonia, M Grote, et al.
Leukemia|December 19, 2017
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cellsB Peter, S Bibi, G Eisenwort, et al.
Leukemia Research|May 30, 2001
Diagnostic criteria and classification of mastocytosis: a consensus proposalP Valent, H P Horny, L Escribano, et al.
Leukemia|August 31, 2016
NDEL1-PDGFRB fusion gene in a myeloid malignancy with eosinophilia associated with resistance to tyrosine kinase inhibitorsK Byrgazov, R Kastner, M Gorna, et al.
Leukemia|August 27, 2015
NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cellsA K Jayavelu, J P Müller, R Bauer, et al.
Pageof 32